Study
|
Exposure to ACEI/ARB
|
Exposure to ACEI/ARB
|
Exposure to ACEI/ARB
|
No Exposure to ACEI/ARB
|
No Exposure to ACEI/ARB
|
No Exposure to ACEI/ARB
|
ARR (%)
|
NNTB
|
RR
(95% CI)
|
|
Total
|
Mortality
Cases
|
Non-mortality
Cases
|
Total
|
Mortality
Cases
|
Non-mortality
Cases
|
|
|
|
Zhang et al., China [11]
|
188
|
7
|
181
|
940
|
92
|
848
|
6.10
|
16
|
0.38
(0.18-0.81)
|
Yang et al., China [13]
|
43
|
2
|
41
|
83
|
11
|
72
|
8.60
|
12
|
0.35
(0.08-1.51)
|
Meng et al., China [14]
|
17
|
0
|
17
|
25
|
1
|
24
|
4.00
|
25
|
0.48
(0.02-11.17)
|
Huang et al., China [18]
|
20
|
0
|
20
|
30
|
3
|
27
|
10.00
|
11
|
0.21
(0.01-3.87)
|
Zeng et al., China [19]1
|
28
|
2
|
26
|
47
|
5
|
42
|
3.50
|
29
|
0.67
(0.14-3.23)
|
Li et al., China [20]
|
115
|
21
|
94
|
247
|
56
|
191
|
4.40
|
23
|
0.81
(0.51-1.26)
|
Ip et al., USA [23]1
|
460
|
137
|
323
|
669
|
262
|
407
|
9.40
|
11
|
0.76
(0.64-0.90)
|
Total/Pooled statistics
|
871
|
169
|
702
|
2041
|
430
|
1611
|
6.70
|
15
|
0.73
(0.63-0.86)
|